These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30543860)

  • 1. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
    Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
    Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
    Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
    Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
    Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
    Front Immunol; 2019; 10():3027. PubMed ID: 31998310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
    Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
    Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.
    Nomura S; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Satake A; Katayama Y; Ohta S; Hayashi K; Ishii K; Ito T
    Transpl Immunol; 2019 Dec; 57():101247. PubMed ID: 31666188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
    Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
    Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation.
    Waterhouse M; Duque-Afonso J; Wäsch R; Bertz H; Finke J
    Transplant Proc; 2013; 45(1):397-401. PubMed ID: 23267813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
    Inoue Y; Matsunawa M; Sano F; Miura I
    Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.
    Le Maux A; Noël G; Birebent B; Grosset JM; Vu N; De Guibert S; Bernard M; Semana G; Amiot L
    Clin Exp Immunol; 2008 Apr; 152(1):50-6. PubMed ID: 18241225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Kordelas L; da Silva Nardi F; Wagner B; Ditschkowski M; Liebregts T; Lindemann M; Heinemann FM; Horn PA; Beelen DW; Rebmann V
    Bone Marrow Transplant; 2018 Sep; 53(9):1149-1156. PubMed ID: 29540850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
    Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.
    Ikezoe T; Yang J; Nishioka C; Yokoyama A
    Bone Marrow Transplant; 2015 Jan; 50(1):113-20. PubMed ID: 25243628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
    Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.